# Kos Biotechnology Partners Announces Strategic Investment in Golden Age Health to Accelerate Global Access to Rare Disease Therapies

- Source: PR Newswire
- Published: 2026-10-26T22:03:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/kos-biotechnology-partners-announces-strategic-investment-in-golden-age-health-to-accelerate-global-access-to-rare-disease-therapies-302919963.html
- Canonical: https://groundlevelnews.com/story/kos-biotechnology-partners-announces-strategic-investment-in-golden-ag-4f6536/

Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President NEW YORK and ATHENS, Greece and SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the U.S. and European...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._